Nicotine Pharmacokinetics and Pharmacodynamics of Two Variants of VM 1.0 Compared to Cigarettes in Adult Current Smokers

A single-center, randomized, controlled, partially blinded, crossover study to evaluate the pharmacokinetics and pharmacodynamics of nicotine following use of two variants of VM 1.0, VM16 and VM32, a nicotine-containing aerosol generator compared to cigarettes in adult current smokers. The participants will be blinded to the variants of VM 1.0 and to the randomized product use sequences. The study will be conducted with 3 periods and 3 sequences.

NCT Number	NCT07135648
Lead Sponsor	Philip Morris Products S.A.
Conditions	Nicotine
Enrollment	16 participants
Start Date	2025-07-17
Primary Completion	2025-07-28 (estimated)
Study Completion	2025-10-06 (estimated)
Updated on ClinicalTrials.gov	2025-08-22